2021 Investor Day
Case Study | Ability to rapidly increase production capacity
•
Background / Need
Needed to significantly increase Astral and
Stellar production in response to critical
global need for ventilators during COVID-19
To maintain production team, needed to
minimize safety and infection risks
-
-
-
•
ResMed solution
Rapidly increased our labor capacity by:
Implementing afternoon and night shifts
Re-skilling team members from other
areas of the factory (e.g., LSR)
Developing a basic training program to
up-skill 10 team members in 10 days
Implemented rapid process changes
-
-
Identified and implemented in less than 4
weeks; re-balanced activities across
various production stations
Reduced Astral and Stellar cycle times
by more than 20% and 25%, respectively
Outcomes
✓ Increased capacity by over 350% across
both platforms
✓ NO COVID-19 infections or transmissions
in the manufacturing center
✓ Produced over 20,000 critical care
Astral and Stellar ventilators, contributing
to more than 150,000 ResMed
ventilators shipped
Established procedures to reduce infections
(e.g., team segregation, increased cleaning,
reduced on-site personnel)
Quickly enhanced internal processes to produce more critical products for our patients
© 2021 ResMed | 2021 Investor Day – Sept 8, 2021
-
73View entire presentation